克罗恩病生物制剂的围手术期治疗

IF 0.4 Q4 SURGERY

Seminars in Colon and Rectal Surgery Pub Date : 2022-03-01 DOI:10.1016/j.scrs.2022.100865

Valery Vilchez MD, Amy L. Lightner MD

{"title":"克罗恩病生物制剂的围手术期治疗","authors":"Valery Vilchez MD, Amy L. Lightner MD","doi":"10.1016/j.scrs.2022.100865","DOIUrl":null,"url":null,"abstract":"<div><p>The medical management of inflammatory bowel disease has shifted towards more frequent use of biologics in the current era. This has led to an increasing number of patients exposed to various classes of biologics in the perioperative period. Evidence regarding the impact of preoperative exposure to this therapy on surgical outcomes remains controversial and difficult to completely assess given different confounding factors associated with the disease process. Regardless, it is imperative that surgeons have an improved understanding of the perioperative optimization of biologics in order to more closely work with both their patients and gastroenterologists to achieve optimal outcomes.</p></div>","PeriodicalId":55956,"journal":{"name":"Seminars in Colon and Rectal Surgery","volume":"33 1","pages":"Article 100865"},"PeriodicalIF":0.4000,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Perioperative management of biologic agents in Crohn's disease\",\"authors\":\"Valery Vilchez MD, Amy L. Lightner MD\",\"doi\":\"10.1016/j.scrs.2022.100865\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>The medical management of inflammatory bowel disease has shifted towards more frequent use of biologics in the current era. This has led to an increasing number of patients exposed to various classes of biologics in the perioperative period. Evidence regarding the impact of preoperative exposure to this therapy on surgical outcomes remains controversial and difficult to completely assess given different confounding factors associated with the disease process. Regardless, it is imperative that surgeons have an improved understanding of the perioperative optimization of biologics in order to more closely work with both their patients and gastroenterologists to achieve optimal outcomes.</p></div>\",\"PeriodicalId\":55956,\"journal\":{\"name\":\"Seminars in Colon and Rectal Surgery\",\"volume\":\"33 1\",\"pages\":\"Article 100865\"},\"PeriodicalIF\":0.4000,\"publicationDate\":\"2022-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Seminars in Colon and Rectal Surgery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1043148922000069\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seminars in Colon and Rectal Surgery","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1043148922000069","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"SURGERY","Score":null,"Total":0}

引用次数: 0

摘要

在当今时代，炎症性肠病的医疗管理已经转向更频繁地使用生物制剂。这导致越来越多的患者在围手术期暴露于各种类型的生物制剂。关于术前接受这种治疗对手术结果的影响的证据仍然存在争议，并且很难完全评估与疾病过程相关的不同混杂因素。无论如何，外科医生必须提高对围手术期生物制剂优化的理解，以便与患者和胃肠病学家更密切地合作，以获得最佳结果。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Perioperative management of biologic agents in Crohn's disease

The medical management of inflammatory bowel disease has shifted towards more frequent use of biologics in the current era. This has led to an increasing number of patients exposed to various classes of biologics in the perioperative period. Evidence regarding the impact of preoperative exposure to this therapy on surgical outcomes remains controversial and difficult to completely assess given different confounding factors associated with the disease process. Regardless, it is imperative that surgeons have an improved understanding of the perioperative optimization of biologics in order to more closely work with both their patients and gastroenterologists to achieve optimal outcomes.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Seminars in Colon and Rectal Surgery SURGERY-

CiteScore

0.60

自引率

0.00%

发文量

期刊介绍： Seminars in Colon and Rectal Surgery offers a comprehensive and coordinated review of a single, timely topic related to the diagnosis and treatment of proctologic diseases. Each issue is an organized compendium of practical information that serves as a lasting reference for colorectal surgeons, general surgeons, surgeons in training and their colleagues in medicine with an interest in colorectal disorders.